Economic benefits of self-management education in COPD.

CONTEXT There is emerging evidence that disease management with self-management education provided by a case manager might benefit COPD patients. OBJECTIVE To determine whether disease management with self-management education is more cost-effective than usual care among previously hospitalized COPD patients. DESIGN Economic analysis in conjunction with a multicenter randomized clinical trial comparing patients conducting self-management with those receiving usual care over a 1-year follow-up period. SETTING Respiratory referral centers. PATIENTS One hundred ninety-one COPD patients who required hospitalization in the year preceding enrollment were recruited from seven respiratory outpatient clinics. INTERVENTION In addition to usual care, patients in the intervention group received standardized education on COPD self-management program called "Living Well with COPD" with ongoing supervision by a case manager. MAIN OUTCOME MEASURES From the perspective of the health-care payer, we compared costs between the two groups and estimated the program cost per hospitalization prevented (incremental cost-effectiveness ratio of the program). We repeated these estimates for several alternate scenarios of patient caseload. RESULTS The additional cost of the self-management program as compared to usual care, $3,778 (2004 Canadian dollars) per patient, exceeded the savings of $3,338 per patient based on the study design with a caseload of 14 patients per case manager. However, through a highly plausible sensitivity analysis, it was showed that if case managers followed up 50 patients per year, the self-management intervention would be cost saving relative to usual care (cost saving of $2,149 per patient; 95% confidence interval, $38 to $4,258). With more realistic potential caseloads of 50 to 70 patients per case manager, estimated program costs would be $1,326 and $1,016 per prevented hospitalization, respectively. CONCLUSION The program of self-management in COPD holds promise for positive economic benefits with increased patient caseload and rising costs of hospitalization.

[1]  N. Anthonisen,et al.  Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. , 1987, Annals of internal medicine.

[2]  T. Krone,et al.  Economic benefits of teaching patients with chronic obstructive pulmonary disease about their illness , 1992, The Lancet.

[3]  J. Collet,et al.  Economic impact of using an immunostimulating agent to prevent severe acute exacerbations in patients with chronic obstructive pulmonary disease. , 2001, Canadian respiratory journal.

[4]  M. Burr,et al.  Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme , 2001, Thorax.

[5]  J. G. Douglas,et al.  Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. , 1997, Thorax.

[6]  R. Carney,et al.  A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. , 1995, The New England journal of medicine.

[7]  M. Lebowitz,et al.  Changes in the normal maximal expiratory flow-volume curve with growth and aging. , 1983, The American review of respiratory disease.

[8]  Russell E Glasgow,et al.  If you build it, will they come? , 2002 .

[9]  Michael R. Chernick,et al.  Bootstrap Methods: A Practitioner's Guide , 1999 .

[10]  J C Yernault,et al.  Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. , 1995, The European respiratory journal.

[11]  J. Schaefer,et al.  Collaborative Management of Chronic Illness , 1997, Annals of Internal Medicine.

[12]  J. Bourbeau,et al.  A Written Action Plan for Early Treatment of COPD Exacerbations: An Important Component to the Reduction of Hospitalizations , 2007 .

[13]  J. Bourbeau,et al.  Self-management and behaviour modification in COPD . , 2004, Patient education and counseling.

[14]  J. Piette,et al.  Impact of automated calls with nurse follow-up on diabetes treatment outcomes in a Department of Veterans Affairs Health Care System: a randomized controlled trial. , 2001, Diabetes care.

[15]  J. Wheeler Can A Disease Self-Management Program Reduce Health Care Costs?: The Case of Older Women With Heart Disease , 2003, Medical care.

[16]  Frode Gallefoss,et al.  Cost-benefit and cost-effectiveness analysis of self-management in patients with COPD--a 1-year follow-up randomized, controlled trial. , 2002, Respiratory medicine.

[17]  J. Collet,et al.  Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant. , 1997, American journal of respiratory and critical care medicine.

[18]  E. Wouters Economic analysis of the Confronting COPD survey: an overview of results. , 2003, Respiratory medicine.

[19]  Elizabeth M. Borycki,et al.  Reduction of Hospital Utilization in Patients With Chronic Obstructive Pulmonary Disease: A Disease-Specific Self-management Intervention , 2003 .

[20]  P. Armstrong,et al.  A systematic review of randomized trials of disease management programs in heart failure. , 2001, The American journal of medicine.

[21]  O. Skjønsberg,et al.  How representative are clinical study patients with asthma or COPD for a larger "real life" population of patients with obstructive lung disease? , 2005, Respiratory medicine.

[22]  Alan D. Lopez,et al.  The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020. , 1996 .

[23]  Bridget Candy,et al.  Effectiveness of innovations in nurse led chronic disease management for patients with chronic obstructive pulmonary disease: systematic review of evidence , 2005, BMJ : British Medical Journal.

[24]  P. Bakke,et al.  Impact of patient education and self-management on morbidity in asthmatics and patients with chronic obstructive pulmonary disease. , 2000, Respiratory medicine.

[25]  S. Hurd,et al.  The impact of COPD on lung health worldwide: epidemiology and incidence. , 2000, Chest.

[26]  M. Feinleib,et al.  Trends in COPD morbidity and mortality in the United States. , 1989, The American review of respiratory disease.

[27]  W. K. Davis,et al.  Community Diabetes Care: A 10-year Perspective , 1994, Diabetes Care.

[28]  J. van der Palen,et al.  Economic evaluation of a comprehensive self-management programme in patients with moderate to severe chronic obstructive pulmonary disease , 2004, Chronic respiratory disease.

[29]  S. T. Buckland,et al.  An Introduction to the Bootstrap. , 1994 .

[30]  Vic Hasselblad,et al.  Interventions used in disease management programmes for patients with chronic illnesswhich ones work? Meta-analysis of published reports , 2002, BMJ : British Medical Journal.

[31]  Michael VonKorff,et al.  Randomised trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care , 2000, BMJ : British Medical Journal.

[32]  T. Seemungal,et al.  Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[33]  C. Caspersen,et al.  The effectiveness of disease and case management for people with diabetes. A systematic review. , 2002, American journal of preventive medicine.

[34]  G. Guyatt,et al.  Economic analysis of respiratory rehabilitation. , 1997, Chest.

[35]  F. Maltais,et al.  Self-management reduces both short- and long-term hospitalisation in COPD , 2005, European Respiratory Journal.

[36]  Ed Wagner More Than a Case Manager , 1998, Annals of Internal Medicine.